Further investigation to delineate the relationship between PrsA1 and PrsA2 and identification of PrsA’s substrates may facilitate the development of therapeutic strategies to limit the progression of the infection and ameliorate complications associated with GAS infection. This evidence concerns the gene GLRX5 and infection.